Not applicableLooking for participantsNCT05571735What this trial is testingImmunogenicity of COVID-19 Vaccines in Tuberculosis PatientsWho this might be right forCovid-19 PandemicsTuberculosis University of Oxford 133
Large-scale testing (Phase 3)Study completedNCT00933790What this trial is testingComparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary TuberculosisWho this might be right forHIV InfectionPulmonary TB Tuberculosis Research Centre, India 331
Not applicableStudy completedNCT07350356What this trial is testingBronchoscopic Role in Early Detection of Endobronchial Tuberculosis in Suspected Pulmonary Tuberculosis Patients.Who this might be right forEndobronchial MassTuberculosis, Pulmonary Ain Shams University 63
Not applicableLooking for participantsNCT06221488What this trial is testingTesting Health Workers At Risk to Advance Our Understanding of TB InfectionWho this might be right forTuberculosisTuberculosis Infection Beth Israel Deaconess Medical Center 300
Not applicableStudy completedNCT04466488What this trial is testingPrevent TB: Choice Architecture for TPT DeliveryWho this might be right forHIV/AIDSTuberculosis Johns Hopkins University 50,798
Not applicableActive Not RecruitingNCT04298905What this trial is testingLeveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SAWho this might be right forAdherence, PatientTBHIV/AIDS+1 more Johns Hopkins University 62
Not applicableStudy completedNCT00134342What this trial is testingTuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised PopulationsWho this might be right forTuberculosis University Health Network, Toronto 203
Testing effectiveness (Phase 2)Ended earlyNCT01424501What this trial is testingSafety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB DiseaseWho this might be right forTuberculosis GlaxoSmithKline 142
Testing effectiveness (Phase 2)Study completedNCT03982277What this trial is testingSafety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral TherapyWho this might be right forTuberculosis Makerere University 130
Not applicableStudy completedNCT02816931What this trial is testingDrug Concentrations in the Treatment of MDR-TB Related to Minimum Inhibitory ConcentrationsWho this might be right forTuberculosis, Multidrug Resistant Karolinska Institutet 37
Early research (Phase 1)WithdrawnNCT03159975What this trial is testingSafety and Immunogenicity Study of GX-70 in TB PatientWho this might be right forPulmonary TuberculosesHigh Risk Factors for RelapseTreatment Failure Yonsei University
Not applicableStudy completedNCT02256839What this trial is testingEvaluation of the QuantiFERON-TB Test.Who this might be right forTuberculosis QIAGEN Gaithersburg, Inc 268
Not applicableStudy completedNCT02253537What this trial is testingEvaluation of the QuantiFERON-TB Test.Who this might be right forTuberculosis QIAGEN Gaithersburg, Inc 15
Post-approval studies (Phase 4)Study completedNCT00164281What this trial is testingStudy of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in BotswanaWho this might be right forTuberculosisHIV Infections Centers for Disease Control and Prevention 1,995
Testing effectiveness (Phase 2)Ended earlyNCT01601626What this trial is testingRifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIVWho this might be right forHIV InfectionTuberculosis Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 71
Large-scale testing (Phase 3)Active Not RecruitingNCT05766267What this trial is testingShort-course Regimens for the Treatment of Pulmonary TuberculosisWho this might be right forTuberculosis, PulmonaryTuberculosis Infection Centers for Disease Control and Prevention 288
Testing effectiveness (Phase 2)Study completedNCT00910871What this trial is testingTo Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.Who this might be right forTuberculosis Janssen Infectious Diseases BVBA 241
Not applicableStudy completedNCT04369326What this trial is testingCommunity Initiated Preventive Therapy for TBWho this might be right forTuberculosis Johns Hopkins University 1,168
Testing effectiveness (Phase 2)WithdrawnNCT05539989What this trial is testingSafety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South AfricaWho this might be right forTuberculosisHIV Infections International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Not applicableStudy completedNCT03470233What this trial is testingPost Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TBWho this might be right forMulti-drug Resistant Tuberculosis Korea Otsuka Pharmaceutical Co., Ltd. 149